2 ASX shares to buy you haven't thought of: expert

Here are a couple of companies not on your radar that a fund manager is recommending you buy at current cheap prices.

There are more than 2,100 companies listed on the ASX, so it's impossible for any one human to keep track of them all.

So it should not surprise you that there are a few bargains that you may not have thought of yet.

Red Leaf Securities chief John Athanasiou suggested two such ASX shares that you may want to consider picking up:

assortment of office stationery and folders with label saying game changer, investment opportunity

Image source: Getty Images

Can this airport hit the jackpot like Sydney did?

Now that Sydney Airport shareholders have been paid out after its private buyout and delisting, Auckland International Airport Limited (ASX: AIA) has become the big aviation infrastructure play.

Athanasiou sees excellent upside for the airport in New Zealand's biggest city.

"A positive for Auckland International Airport is the New Zealand Government bringing forward its plans to re-open the country's borders to international travellers," he told The Bull.

"The return of international travel may encourage AIA management to resume dividends."

According to The Motley Fool website, the company has not paid out a dividend since 2009. However, CMC Markets forecasts a 5.8 cents per share payout in 2023 and a 15.3 cent yield in 2024.

The resumption of dividends would be a massive catalyst, said Athanasiou. Maybe it will even end up with the same fate as its Sydney cousin.

"If the company starts paying dividends, AIA is likely to attract interest from global funds seeking yield from quality infrastructure assets."

Auckland Airport shares have dipped more than 4% for the year so far. The stock price hasn't yet approached its pre-COVID peaks.

Cashed-up Aussies spend big on pets

Online marketplace Mad Paws Holdings Ltd (ASX: MPA) only listed 13 months ago, hoping to ride the huge interest in growth stocks.

The company claimed at the time the initial public offer was oversubscribed four times over.

The recent market rotation to cyclicals has unfortunately meant the stock price has merely gone sideways from its IPO price of 20 cents per share.

But Athanasiou is upbeat after his team visited the business in real life recently.

"The pet chemist business is potentially the most lucrative segment of the company's operations, as it's able to sell pet pharmaceutical products at an attractive premium to repeat customers," he said.

"There's plenty of room for growth for the pet chemist business, as it uses the Mad Paws platform to sell their products."

Athanasiou told The Motley Fool in February that Australians are "not shy" of spending big on their fur (or feather) children.

"We all know tailwinds in the industry of increased levels of pet ownership. Everyone bought a pet during lockdown to have some company."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »